Wealth Analytics Partners’s Boston Scientific BSX Stock Holding History

Wealth Analytics Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$10.9K	Buy	+250	New	+$11.6K	﹤0.01%	133

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Fisher Funds Management Auckland, New Zealand $3.44B AUM 17.27% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Wealth Analytics Partners's BSX Position: Q3 2026 in Review

Wealth Analytics Partners opened a new position in Boston Scientific (BSX) in Q3 2026: 250 shares worth $10.9K. The stake represents ﹤0.01% of the portfolio and ranks #133 among its holdings.

267 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

Wealth Analytics Partners held 250 shares of Boston Scientific worth $10.9K as of Q3 2026.
Boston Scientific was a new Wealth Analytics Partners position in Q3 2026.
Boston Scientific made up ﹤0.01% of Wealth Analytics Partners's portfolio in Q3 2026, its #133 holding.
267 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Wealth Analytics Partners's 13F filing for Q3 2026, filed 19 Oct 2026.